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tTATE-OF-THE-ART PAPER2187The Transradial Approach to PCIunil V. Rao, Mauricio G. Cohen, David E. Kandzari, Olivier F. Bertrand, Ian C. Gilchrist
eriprocedural bleeding complications after percutaneous coronary intervention (PCI) are
ssociated with increased short- and long-term morbidity and mortality. Mounting evidence
uggests that transradial rather than transfemoral approaches to PCI may lead to greater
eductions in bleeding. In this review, Rao and colleagues examine the history of the
ransradial approach and the factors that have limited its adoption. The literature supporting
he transradial approach as well as several unresolved issues affecting broader application are
escribed.VIEWPOINT IEWPOINT2196Medical Professionalism and Health Care Reformrthur Garson, Jr, Carolyn L. Engelhard, John C. Lewin
ow that health care reform legislation has passed, it is more important than ever for
ardiologists to provide leadership by demonstrating professionalism, most simply defined as
putting the patient before the doctor,” as argued by Garson and colleagues in their
iewpoint paper. Professionalism mandates that cardiologists advocate for appropriate
ayment incentives. Payments allow fair compensation and ensure that cardiologists are
ccessible to patients in the appropriate location at the appropriate time. This expanded view
f medical professionalism includes a responsibility to communities and to society. Physicians
re poised to lead efforts in 5 areas of reform-minded health care delivery: appropriate
ervices, “system professionalism,” a “National Institute for Keeping People Healthy,” covering
he uninsured, and providing access for all with new approaches to the workforce.(continued on page A-26)
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pNTERVENTIONAL CARDIOLOGY2201No Benefit for N-Acetylcysteine in STEMI Patients Undergoing Primary PCI0
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N-acetylcysteine
Placebo
Creatinine clearance
P=0.28 P=0.46 P=0.08olger Thiele, Lysann Hildebrand, Carmen Schirdewahn, Ingo Eitel, Volker Adams, Georg Fuernau,
andra Erbs, Axel Linke, Klaus-Werner Diederich, Marek Nowak, Steffen Desch, Matthias Gutberlet,
erhard Schuler
his trial assessed the ability of N-acetylcysteine to reduce the incidence of contrast-induced
ephropathy (CIN) and reperfusion injury in ST-segment elevation myocardial infarction
atients undergoing primary percutaneous coronary intervention. Subjects were randomized to
igh-dose N-acetylcysteine or placebo, with both groups receiving hydration. There was no
ifference in the primary end point of CIN, defined as 25% increase in serum creatinine
evel, with no evidence of benefit in those with baseline reduced renal function or in
reventing transient dialysis. Likewise, there was no evidence of preventing reperfusion injury
s measured by the myocardial salvage index. High-dose intravenous N-acetylcysteine does
ot provide an additional clinical benefit to hydration in preventing CIN or myocardial
eperfusion injury.ditorial Comment: Roxana Mehran, Somjot Brar, George Dangas, p. 2210ARDIAC IMAGING IN HEART FAILURE
2212yocardial 123I-mIBG Imaging Predicts Risk of
Cardiac Events in Patients With Systolic HFrnold F. Jacobson, Roxy Senior, Manuel D. Cerqueira, Nathan D. Wong, Gregory S. Thomas,
ictor A. Lopez, Denis Agostini, Fred Weiland, Harish Chandna, Jagat Narula, on behalf of the
DMIRE-HF Investigators
ingle-center studies have shown worse prognosis for heart failure (HF) patients with reduced
odine-123 meta-iodobenzylguanidine (123I-mIBG) myocardial uptake. This is believed to
eflect reduced pre-synaptic reuptake of norepinephrine. The ADMIRE-HF (AdreView
yocardial Imaging for Risk Evaluation in Heart Failure) study enrolled almost 1,000
ubjects with New York Heart Association functional class II/III HF and left ventricular
jection fraction (LVEF) 35%. Studies were scored based on the heart/mediastinum uptake
atio (H/M). Two-year event rates were 15% for H/M 1.60 compared with 37% for H/M
1.60. 123I-mIBG imaging also provided additional discrimination in analyses of interactions
etween B-type natriuretic peptide and LVEF. The ADMIRE-HF study provides
rospective validation of the prognostic value of 123I-mIBG scintigraphy.
ditorial Comment: H. William Strauss, Michelle N. Johnson, Heiko Schöder, Nagara Tamaki,
. 2222(continued on page A-30)
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EEART RHYTHM DISORDERS
2225-Dimer Levels Predict Risk of
Thromboembolic Events in Patients With AF on Warfarinsuneaki Sadanaga, Motoaki Sadanaga, Satoshi Ogawa
-dimer originates from the formation and lysis of cross-linked fibrin and therefore reflects
ctivation of both coagulation and fibrinolysis. Sadanga and colleagues hypothesized that
levated D-dimer levels would predict subsequent thromboembolic and cardiovascular events
n patients with atrial fibrillation (AF) being treated with warfarin. Almost 300 patients with
F treated with warfarin (target prothrombin time/international normalized ratio: 1.5 to 3.0)
ad D-dimer levels measured. D-dimer levels were elevated (0.5 g/ml) in 23%; these
atients were nearly 16 times more likely to suffer a thromboembolic event during 2 years of
ollow-up. D-dimer might be a useful marker for stratifying the risk of thromboembolic
vents in patients with AF on oral anticoagulant therapy.EGENERATIVE CARDIOLOGY2232EPCs Appear Superior to MSCs in Porcine Modelhristophe Dubois, Xiaoshun Liu, Piet Claus, Glenn Marsboom, Peter Pokreisz, Sara Vandenwijngaert,
élène Dépelteau, Witold Streb, Lertlak Chaothawee, Frederik Maes, Olivier Gheysens, Zeger Debyser,
ilde Gillijns, Marijke Pellens, Thierry Vandendriessche, Marinee Chuah, Desiré Collen, Erik Verbeken,
nn Belmans, Frans Van de Werf, Jan Bogaert, Stefan Janssens
ubois and colleagues compared the efficacy of progenitor cells from 2 different populations
or their ability to limit myocardial damage when infused 1 week after a temporary arterial
cclusion in a porcine model. Progenitor cells were either endothelial progenitor cells (EPCs)
r mesenchymal stem cells (MSCs) and were infused into the infarct-related artery. The
nimals underwent serial magnetic resonance imaging. Those randomized to EPCs had no
hange in end-systolic volume, while those randomized to MSCs had significant increases in
nd-systolic and -diastolic volume. EPCs also improved infarct remodeling as evidenced by
maller transmural extent of delayed enhancement, greater vascular density, and a trend
oward enhanced antiapoptotic gene expression in the infarct border zone.EGENERATIVE CARDIOLOGY2244MSCs Provide Better Results Than Hematopoietic Precursorsna Armiña´n, Carolina Gandı´a, J. Manuel Garcı´a-Verdugo, Elisa Lledo´, César Trigueros,
mparo Ruiz-Saurı´, Marı´a Dolores Miñana, Pilar Solves, Rafael Paya´, J. Anastasio Montero,
ilar Sepúlveda
imilar to the previous paper by Dubois and colleagues, Armiña´n and colleagues compared
he ability of 2 human stem cell populations to repair cardiac function after an infarction. In a
ude mouse model, CD34 hematopoietic cell progenitors derived from umbilical cord
lood were compared to mesenchymal stem cells (MSCs) isolated from bone marrow. Both
mproved left ventricular function and increased cell proliferation and neoangiogenesis
ompared with saline injected into the myocardium 1 week after coronary artery ligation.
owever, MSCs were superior in reducing infarct size and preventing ventricular remodeling.
ditorial Comment: Andre Terzic, Timothy J. Nelson, p. 2254(continued on page A-34)
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tRE-CLINICAL RESEARCH2258p19ARF Deficiency Aggravates Atherosclerosis by Inhibiting Apoptosiserminia Gonza´lez-Navarro, Yafa Naim Abu Nabah, Ángela Vinué, Marı´a J. Andrés-Manzano,
anuel Collado, Manuel Serrano, Vicente Andrés
ecent genome-wide association studies have linked atherosclerotic diseases to a region on
uman chromosome 9p21 near the CDKN2A locus. Gonza´lez-Navarro and colleagues
nvestigated the role in atherosclerosis of the tumor suppressor gene ARF encoded by the
DKN2A gene. Atherosclerosis-prone apolipoprotein E (apoE)-null and doubly-deficient
poE-p19ARF mice were fed an atherogenic diet and sacrificed to quantify atherosclerotic
urden in the aorta. Mice lacking p19ARF had more extensive atherosclerosis but no
ifferences in body weight or plasma lipoproteins. In cultured macrophages and vascular
mooth muscle cells, p19ARF deficiency significantly attenuated apoptosis. These findings
stablish a link between p19ARF, plaque apoptosis, and atherosclerosis.ditorial Comment: Rainer Wessely, p. 2269YEAR IN CARDIOLOGY SERIES EAR IN CARDIOLOGY SERIES2272The Year in Interventional Cardiologyimon R. Dixon, Cindy L. Grines, William W. O’Neill
ixon and colleagues provide a fast-paced review of the major scientific work in the field of
nterventional cardiology in 2009. This paper is meant to provide a broad overview of the
eld for general cardiologists, as well as a framework for more detailed study for those with a
pecific interest in interventional cardiology. It begins with a review of the updated guidelines
or the management of ST-segment elevation myocardial infarction patients and ends with
he controversy over the utility of patent foramen ovale closure.
